Federation des caisses Desjardins du Quebec’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$417 Hold
86
﹤0.01% 2590
2025
Q1
$127 Buy
86
+4
+5% +$6 ﹤0.01% 2582
2024
Q4
$156 Sell
82
-344
-81% -$654 ﹤0.01% 2464
2024
Q3
$1.37K Sell
426
-99
-19% -$319 ﹤0.01% 2285
2024
Q2
$3.67K Sell
525
-466
-47% -$3.26K ﹤0.01% 2017
2024
Q1
$17.9K Sell
991
-182
-16% -$3.3K ﹤0.01% 1666
2023
Q4
$12.5K Sell
1,173
-1,631
-58% -$17.4K ﹤0.01% 1699
2023
Q3
$55.5K Sell
2,804
-10
-0.4% -$198 ﹤0.01% 1283
2023
Q2
$215K Buy
2,814
+103
+4% +$7.88K ﹤0.01% 944
2023
Q1
$256K Buy
2,711
+245
+10% +$23.2K ﹤0.01% 893
2022
Q4
$240K Sell
2,466
-11
-0.4% -$1.07K ﹤0.01% 984
2022
Q3
$639K Buy
2,477
+420
+20% +$108K 0.01% 710
2022
Q2
$383K Buy
2,057
+447
+28% +$83.1K ﹤0.01% 874
2022
Q1
$157K Buy
1,610
+680
+73% +$66.5K ﹤0.01% 1214
2021
Q4
$152K Buy
930
+195
+27% +$31.9K ﹤0.01% 1245
2021
Q3
$201K Buy
735
+86
+13% +$23.5K ﹤0.01% 1161
2021
Q2
$257K Buy
649
+14
+2% +$5.55K ﹤0.01% 1107
2021
Q1
$343K Buy
635
+47
+8% +$25.4K ﹤0.01% 947
2020
Q4
$222K Buy
588
+12
+2% +$4.53K ﹤0.01% 1033
2020
Q3
$218K Hold
576
﹤0.01% 849
2020
Q2
$283K Buy
576
+101
+21% +$49.7K ﹤0.01% 758
2020
Q1
$175K Buy
475
+7
+1% +$2.57K ﹤0.01% 895
2019
Q4
$332K Buy
468
+6
+1% +$4.25K ﹤0.01% 896
2019
Q3
$296K Buy
462
+55
+14% +$35.3K ﹤0.01% 928
2019
Q2
$356K Buy
407
+105
+35% +$91.7K 0.01% 865
2019
Q1
$175K Buy
302
+174
+136% +$101K ﹤0.01% 1013
2018
Q4
$35.8K Buy
128
+103
+412% +$28.8K ﹤0.01% 1364
2018
Q3
$12.1K Hold
25
﹤0.01% 1683
2018
Q2
$11.4K Buy
25
+20
+400% +$9.11K ﹤0.01% 1720
2018
Q1
$2.88K Buy
+5
New +$2.88K ﹤0.01% 1959